|
|
| | PPARδ agonist 11 Basic information |
| Product Name: | PPARδ agonist 11 | | Synonyms: | PPARδ agonist 11;Acetic acid, 2-[2-methyl-4-[[[5-[4-(trifluoromethyl)phenyl]-1,3,4-thiadiazol-2-yl]methyl]thio]phenoxy]- | | CAS: | 2982696-04-6 | | MF: | C19H15F3N2O3S2 | | MW: | 440.46 | | EINECS: | | | Product Categories: | | | Mol File: | 2982696-04-6.mol |  |
| | PPARδ agonist 11 Chemical Properties |
| Boiling point | 570.9±60.0 °C(predicted) | | density | 1.49±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 3.16±0.10(predicted) |
| | PPARδ agonist 11 Usage And Synthesis |
| Uses | PPARδ agonist 11 (Compound 11) is a selective agonist for PPARδ with an EC50 of 20 nM. PPARδ agonist 11 reduces the levels of nitrite oxide (NO), proinflammatory cytokines TNFα and IL-6 in LPS (HY-D1056)-stimulated RAW264.7 cell, and exhibits anti-inflammatory efficacy via NF-κB pathway. PPARδ agonist 11 exhibits good stability in human liver microsomes and plasma. PPARδ agonist 11 ameliorates Carrageenan (HY-125474)-induced foot edema[1]. | | IC 50 | hPPARδ: 0.02 μM (EC50); hPPARα: 8 μM (EC50) | | References | [1] Kim J, et al., Discovery of the therapeutic potential of PPARδ agonist bearing 1,3,4- thiadiazole in inflammatory disorders. Eur J Med Chem. 2024 Sep 12;279:116856. DOI:10.1016/j.ejmech.2024.116856 |
| | PPARδ agonist 11 Preparation Products And Raw materials |
|